Global Transdermal Drug Delivery System Market Insights and Forecast to 2028

Publisher Name :
Date: 25-Jan-2022
No. of pages: 117
Inquire Before Buying

Transdermal Drug Delivery System market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Fentanyl

- Nitroglycerin

- Estradiol

- Nicotine

- Other

Segment by Application

- OTC

- Rx

By Company

- Hisamitsu

- Mylan

- GSK

- Novartis

- Teve (Actavis)

- Johnson & Johnson

- Lohmann

- Teikoku Seiyaku

- Bayer

- Lingrui

- Sanofi

- Qizheng

- Endo

- Huarun 999

- Haw Par

- Nichiban

- Mentholatum

- Laboratoires Genevrier

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Transdermal Drug Delivery System Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 OTC
1.3.3 Rx
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery System Market Perspective (2017-2028)
2.2 Transdermal Drug Delivery System Growth Trends by Region
2.2.1 Transdermal Drug Delivery System Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Transdermal Drug Delivery System Historic Market Size by Region (2017-2022)
2.2.3 Transdermal Drug Delivery System Forecasted Market Size by Region (2023-2028)
2.3 Transdermal Drug Delivery System Market Dynamics
2.3.1 Transdermal Drug Delivery System Industry Trends
2.3.2 Transdermal Drug Delivery System Market Drivers
2.3.3 Transdermal Drug Delivery System Market Challenges
2.3.4 Transdermal Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery System Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2017-2022)
3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2017-2022)
3.2 Global Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transdermal Drug Delivery System Revenue
3.4 Global Transdermal Drug Delivery System Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery System Revenue in 2021
3.5 Transdermal Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Transdermal Drug Delivery System Product Solution and Service
3.7 Date of Enter into Transdermal Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery System Breakdown Data by Type
4.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2017-2022)
4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2023-2028)
5 Transdermal Drug Delivery System Breakdown Data by Application
5.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2017-2022)
5.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Transdermal Drug Delivery System Market Size (2017-2028)
6.2 North America Transdermal Drug Delivery System Market Size by Type
6.2.1 North America Transdermal Drug Delivery System Market Size by Type (2017-2022)
6.2.2 North America Transdermal Drug Delivery System Market Size by Type (2023-2028)
6.2.3 North America Transdermal Drug Delivery System Market Share by Type (2017-2028)
6.3 North America Transdermal Drug Delivery System Market Size by Application
6.3.1 North America Transdermal Drug Delivery System Market Size by Application (2017-2022)
6.3.2 North America Transdermal Drug Delivery System Market Size by Application (2023-2028)
6.3.3 North America Transdermal Drug Delivery System Market Share by Application (2017-2028)
6.4 North America Transdermal Drug Delivery System Market Size by Country
6.4.1 North America Transdermal Drug Delivery System Market Size by Country (2017-2022)
6.4.2 North America Transdermal Drug Delivery System Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery System Market Size (2017-2028)
7.2 Europe Transdermal Drug Delivery System Market Size by Type
7.2.1 Europe Transdermal Drug Delivery System Market Size by Type (2017-2022)
7.2.2 Europe Transdermal Drug Delivery System Market Size by Type (2023-2028)
7.2.3 Europe Transdermal Drug Delivery System Market Share by Type (2017-2028)
7.3 Europe Transdermal Drug Delivery System Market Size by Application
7.3.1 Europe Transdermal Drug Delivery System Market Size by Application (2017-2022)
7.3.2 Europe Transdermal Drug Delivery System Market Size by Application (2023-2028)
7.3.3 Europe Transdermal Drug Delivery System Market Share by Application (2017-2028)
7.4 Europe Transdermal Drug Delivery System Market Size by Country
7.4.1 Europe Transdermal Drug Delivery System Market Size by Country (2017-2022)
7.4.2 Europe Transdermal Drug Delivery System Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery System Market Size (2017-2028)
8.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Type
8.2.1 Asia-Pacific Transdermal Drug Delivery System Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Transdermal Drug Delivery System Market Share by Type (2017-2028)
8.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Application
8.3.1 Asia-Pacific Transdermal Drug Delivery System Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Transdermal Drug Delivery System Market Share by Application (2017-2028)
8.4 Asia-Pacific Transdermal Drug Delivery System Market Size by Region
8.4.1 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery System Market Size (2017-2028)
9.2 Latin America Transdermal Drug Delivery System Market Size by Type
9.2.1 Latin America Transdermal Drug Delivery System Market Size by Type (2017-2022)
9.2.2 Latin America Transdermal Drug Delivery System Market Size by Type (2023-2028)
9.2.3 Latin America Transdermal Drug Delivery System Market Share by Type (2017-2028)
9.3 Latin America Transdermal Drug Delivery System Market Size by Application
9.3.1 Latin America Transdermal Drug Delivery System Market Size by Application (2017-2022)
9.3.2 Latin America Transdermal Drug Delivery System Market Size by Application (2023-2028)
9.3.3 Latin America Transdermal Drug Delivery System Market Share by Application (2017-2028)
9.4 Latin America Transdermal Drug Delivery System Market Size by Country
9.4.1 Latin America Transdermal Drug Delivery System Market Size by Country (2017-2022)
9.4.2 Latin America Transdermal Drug Delivery System Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery System Market Size (2017-2028)
10.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Type
10.2.1 Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Transdermal Drug Delivery System Market Share by Type (2017-2028)
10.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Application
10.3.1 Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Transdermal Drug Delivery System Market Share by Application (2017-2028)
10.4 Middle East & Africa Transdermal Drug Delivery System Market Size by Country
10.4.1 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hisamitsu
11.1.1 Hisamitsu Company Details
11.1.2 Hisamitsu Business Overview
11.1.3 Hisamitsu Transdermal Drug Delivery System Introduction
11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.1.5 Hisamitsu Recent Developments
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery System Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.2.5 Mylan Recent Developments
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Transdermal Drug Delivery System Introduction
11.3.4 GSK Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.3.5 GSK Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery System Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Teve (Actavis)
11.5.1 Teve (Actavis) Company Details
11.5.2 Teve (Actavis) Business Overview
11.5.3 Teve (Actavis) Transdermal Drug Delivery System Introduction
11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.5.5 Teve (Actavis) Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Transdermal Drug Delivery System Introduction
11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.6.5 Johnson & Johnson Recent Developments
11.7 Lohmann
11.7.1 Lohmann Company Details
11.7.2 Lohmann Business Overview
11.7.3 Lohmann Transdermal Drug Delivery System Introduction
11.7.4 Lohmann Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.7.5 Lohmann Recent Developments
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Details
11.8.2 Teikoku Seiyaku Business Overview
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Introduction
11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.8.5 Teikoku Seiyaku Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Transdermal Drug Delivery System Introduction
11.9.4 Bayer Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.9.5 Bayer Recent Developments
11.10 Lingrui
11.10.1 Lingrui Company Details
11.10.2 Lingrui Business Overview
11.10.3 Lingrui Transdermal Drug Delivery System Introduction
11.10.4 Lingrui Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.10.5 Lingrui Recent Developments
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Transdermal Drug Delivery System Introduction
11.11.4 Sanofi Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.11.5 Sanofi Recent Developments
11.12 Qizheng
11.12.1 Qizheng Company Details
11.12.2 Qizheng Business Overview
11.12.3 Qizheng Transdermal Drug Delivery System Introduction
11.12.4 Qizheng Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.12.5 Qizheng Recent Developments
11.13 Endo
11.13.1 Endo Company Details
11.13.2 Endo Business Overview
11.13.3 Endo Transdermal Drug Delivery System Introduction
11.13.4 Endo Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.13.5 Endo Recent Developments
11.14 Huarun 999
11.14.1 Huarun 999 Company Details
11.14.2 Huarun 999 Business Overview
11.14.3 Huarun 999 Transdermal Drug Delivery System Introduction
11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.14.5 Huarun 999 Recent Developments
11.15 Haw Par
11.15.1 Haw Par Company Details
11.15.2 Haw Par Business Overview
11.15.3 Haw Par Transdermal Drug Delivery System Introduction
11.15.4 Haw Par Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.15.5 Haw Par Recent Developments
11.16 Nichiban
11.16.1 Nichiban Company Details
11.16.2 Nichiban Business Overview
11.16.3 Nichiban Transdermal Drug Delivery System Introduction
11.16.4 Nichiban Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.16.5 Nichiban Recent Developments
11.17 Mentholatum
11.17.1 Mentholatum Company Details
11.17.2 Mentholatum Business Overview
11.17.3 Mentholatum Transdermal Drug Delivery System Introduction
11.17.4 Mentholatum Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.17.5 Mentholatum Recent Developments
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Details
11.18.2 Laboratoires Genevrier Business Overview
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Introduction
11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2017-2022)
11.18.5 Laboratoires Genevrier Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Fentanyl
Table 3. Key Players of Nitroglycerin
Table 4. Key Players of Estradiol
Table 5. Key Players of Nicotine
Table 6. Key Players of Other
Table 7. Global Transdermal Drug Delivery System Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Transdermal Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Transdermal Drug Delivery System Market Share by Region (2017-2022)
Table 11. Global Transdermal Drug Delivery System Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Transdermal Drug Delivery System Market Share by Region (2023-2028)
Table 13. Transdermal Drug Delivery System Market Trends
Table 14. Transdermal Drug Delivery System Market Drivers
Table 15. Transdermal Drug Delivery System Market Challenges
Table 16. Transdermal Drug Delivery System Market Restraints
Table 17. Global Transdermal Drug Delivery System Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Transdermal Drug Delivery System Revenue Share by Players (2017-2022)
Table 19. Global Top Transdermal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2021)
Table 20. Ranking of Global Top Transdermal Drug Delivery System Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery System Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Transdermal Drug Delivery System Product Solution and Service
Table 24. Date of Enter into Transdermal Drug Delivery System Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Transdermal Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Transdermal Drug Delivery System Revenue Market Share by Type (2017-2022)
Table 28. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Transdermal Drug Delivery System Revenue Market Share by Type (2023-2028)
Table 30. Global Transdermal Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Transdermal Drug Delivery System Revenue Share by Application (2017-2022)
Table 32. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Transdermal Drug Delivery System Revenue Share by Application (2023-2028)
Table 34. North America Transdermal Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Transdermal Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Transdermal Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Transdermal Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Transdermal Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Transdermal Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Transdermal Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Transdermal Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Transdermal Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Transdermal Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Transdermal Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Transdermal Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Transdermal Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Transdermal Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Transdermal Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Transdermal Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Transdermal Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Transdermal Drug Delivery System Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Transdermal Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Transdermal Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Transdermal Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Transdermal Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Transdermal Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Transdermal Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Transdermal Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Transdermal Drug Delivery System Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Transdermal Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Transdermal Drug Delivery System Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Transdermal Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Transdermal Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 64. Hisamitsu Company Details
Table 65. Hisamitsu Business Overview
Table 66. Hisamitsu Transdermal Drug Delivery System Product
Table 67. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 68. Hisamitsu Recent Developments
Table 69. Mylan Company Details
Table 70. Mylan Business Overview
Table 71. Mylan Transdermal Drug Delivery System Product
Table 72. Mylan Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 73. Mylan Recent Developments
Table 74. GSK Company Details
Table 75. GSK Business Overview
Table 76. GSK Transdermal Drug Delivery System Product
Table 77. GSK Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 78. GSK Recent Developments
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Transdermal Drug Delivery System Product
Table 82. Novartis Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 83. Novartis Recent Developments
Table 84. Teve (Actavis) Company Details
Table 85. Teve (Actavis) Business Overview
Table 86. Teve (Actavis) Transdermal Drug Delivery System Product
Table 87. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 88. Teve (Actavis) Recent Developments
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Transdermal Drug Delivery System Product
Table 92. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 93. Johnson & Johnson Recent Developments
Table 94. Lohmann Company Details
Table 95. Lohmann Business Overview
Table 96. Lohmann Transdermal Drug Delivery System Product
Table 97. Lohmann Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 98. Lohmann Recent Developments
Table 99. Teikoku Seiyaku Company Details
Table 100. Teikoku Seiyaku Business Overview
Table 101. Teikoku Seiyaku Transdermal Drug Delivery System Product
Table 102. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 103. Teikoku Seiyaku Recent Developments
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Transdermal Drug Delivery System Product
Table 107. Bayer Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 108. Bayer Recent Developments
Table 109. Lingrui Company Details
Table 110. Lingrui Business Overview
Table 111. Lingrui Transdermal Drug Delivery System Product
Table 112. Lingrui Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 113. Lingrui Recent Developments
Table 114. Sanofi Company Details
Table 115. Sanofi Business Overview
Table 116. Sanofi Transdermal Drug Delivery System Product
Table 117. Sanofi Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 118. Sanofi Recent Developments
Table 119. Qizheng Company Details
Table 120. Qizheng Business Overview
Table 121. Qizheng Transdermal Drug Delivery System Product
Table 122. Qizheng Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 123. Qizheng Recent Developments
Table 124. Endo Company Details
Table 125. Endo Business Overview
Table 126. Endo Transdermal Drug Delivery System Product
Table 127. Endo Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 128. Endo Recent Developments
Table 129. Huarun 999 Company Details
Table 130. Huarun 999 Business Overview
Table 131. Huarun 999 Transdermal Drug Delivery System Product
Table 132. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 133. Huarun 999 Recent Developments
Table 134. Haw Par Company Details
Table 135. Haw Par Business Overview
Table 136. Haw Par Transdermal Drug Delivery System Product
Table 137. Haw Par Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 138. Haw Par Recent Developments
Table 139. Nichiban Company Details
Table 140. Nichiban Business Overview
Table 141. Nichiban Transdermal Drug Delivery System Product
Table 142. Nichiban Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 143. Nichiban Recent Developments
Table 144. Mentholatum Company Details
Table 145. Mentholatum Business Overview
Table 146. Mentholatum Transdermal Drug Delivery System Product
Table 147. Mentholatum Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 148. Mentholatum Recent Developments
Table 149. Laboratoires Genevrier Company Details
Table 150. Laboratoires Genevrier Business Overview
Table 151. Laboratoires Genevrier Transdermal Drug Delivery System Product
Table 152. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2017-2022) & (US$ Million)
Table 153. Laboratoires Genevrier Recent Developments
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Drug Delivery System Market Share by Type: 2021 VS 2028
Figure 2. Fentanyl Features
Figure 3. Nitroglycerin Features
Figure 4. Estradiol Features
Figure 5. Nicotine Features
Figure 6. Other Features
Figure 7. Global Transdermal Drug Delivery System Market Share by Application: 2021 VS 2028
Figure 8. OTC Case Studies
Figure 9. Rx Case Studies
Figure 10. Transdermal Drug Delivery System Report Years Considered
Figure 11. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Transdermal Drug Delivery System Market Share by Region: 2021 VS 2028
Figure 14. Global Transdermal Drug Delivery System Market Share by Players in 2021
Figure 15. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2021
Figure 17. North America Transdermal Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Transdermal Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 19. North America Transdermal Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 20. North America Transdermal Drug Delivery System Market Size Share by Country (2017-2028)
Figure 21. United States Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Transdermal Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Transdermal Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 25. Europe Transdermal Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 26. Europe Transdermal Drug Delivery System Market Size Share by Country (2017-2028)
Figure 27. Germany Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Transdermal Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Transdermal Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Transdermal Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Transdermal Drug Delivery System Market Size Share by Region (2017-2028)
Figure 37. China Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Transdermal Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Transdermal Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Transdermal Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Transdermal Drug Delivery System Market Size Share by Country (2017-2028)
Figure 47. Mexico Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Transdermal Drug Delivery System Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Transdermal Drug Delivery System Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Transdermal Drug Delivery System Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Transdermal Drug Delivery System Market Size Share by Country (2017-2028)
Figure 53. Turkey Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Transdermal Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2017-2022)
Figure 57. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2017-2022)
Figure 58. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2017-2022)
Figure 60. Teve (Actavis) Revenue Growth Rate in Transderm
  • Global Gold Nanoparticles Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121
    Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......
  • Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......
  • Global Gold Nanoparticles Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......
  • Global Liposome Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......
  • Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......
  • Global Liposomes Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......
  • Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129
    According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......
  • Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs